Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-4-30
pubmed:abstractText
To assess the impact of fee-for-service (FFS) versus HMO medical insurance coverage on receipt of aspirin, beta-blockers, and calcium channel blockers at the time of hospital discharge following an acute myocardial infarction.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0884-8734
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-81
pubmed:dateRevised
2009-2-24
pubmed:meshHeading
pubmed-meshheading:10051777-Adrenergic beta-Antagonists, pubmed-meshheading:10051777-Adult, pubmed-meshheading:10051777-Aspirin, pubmed-meshheading:10051777-Calcium Channel Blockers, pubmed-meshheading:10051777-Cardiovascular Agents, pubmed-meshheading:10051777-Confidence Intervals, pubmed-meshheading:10051777-Drug Utilization, pubmed-meshheading:10051777-Fee-for-Service Plans, pubmed-meshheading:10051777-Female, pubmed-meshheading:10051777-Health Maintenance Organizations, pubmed-meshheading:10051777-Humans, pubmed-meshheading:10051777-Male, pubmed-meshheading:10051777-Massachusetts, pubmed-meshheading:10051777-Middle Aged, pubmed-meshheading:10051777-Multivariate Analysis, pubmed-meshheading:10051777-Myocardial Infarction, pubmed-meshheading:10051777-Odds Ratio, pubmed-meshheading:10051777-Patient Discharge, pubmed-meshheading:10051777-Population Surveillance, pubmed-meshheading:10051777-Prospective Studies
pubmed:year
1999
pubmed:articleTitle
Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.
pubmed:affiliation
Section for Health Services Research, Division of General Medicine/Primary Care/Geriatrics, University of Massachusetts Medical School, Worcester 01655, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Multicenter Study